Prioritization of Biomedical innovation by developed and developing nations as a key driver of economy under conditions of globalization is a recent phenomenon. Biomedical innovation spans over a wide range of technological platforms like stem cell therapies and tissue engineering under regenerative medicine, genetic engineering, bioinformatics, pharmacogenomics etc. under personalized medicine. The process of biomedical innova-tion, from basic science, through clinical ex-perimentation and clinical trials, to the thera-peutic products and services is characterized by uncertainty. The overlapping of uncer-tainty along with the attempts by countries like India and China to capitalize on these technologies and determine the trajectory of bioeconomy has transformed biomedical in-novation in to a techno-political space with national and international consequences. The dynamics of biomedical innovation space is characterized by state, national firms and ser-vice providers, multinational corporations and civil society organizations competing to deter-mine the emerging governance space of bio-medical innovation.
In this context the Centre for Studies in Science Policy (CSSP), Jawaharlal Nehru University, New Delhi in collaboration with King’s College, London organised a two day workshop to explore the linkages between biomedical innovation and governance with a focus on consumers of biomedical innovation. Addressing the question of the implications of emerging governance space of bio-medical innovation for consumers in different biomedical innovation models?
The event was attended by a mix of 50 eminent scholars from all over India, policymakers and select industry leaders.
Participation of the event was by invitation only.